These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 35077882)
21. Study on the mechanism of Wuzi-Yanzong-Wan-medicated serum interfering with the mitochondrial permeability transition pore in the GC-2 cell induced by atractyloside. Wu DL; Wang TS; Liu HJ; Zhang W; Tong XH; Peng DY; Kong LY Chin J Nat Med; 2022 Apr; 20(4):282-289. PubMed ID: 35487598 [TBL] [Abstract][Full Text] [Related]
22. The mitochondrial ATP synthase is a negative regulator of the mitochondrial permeability transition pore. Pekson R; Liang FG; Axelrod JL; Lee J; Qin D; Wittig AJH; Paulino VM; Zheng M; Peixoto PM; Kitsis RN Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2303713120. PubMed ID: 38091291 [TBL] [Abstract][Full Text] [Related]
23. Sirtuin 3 and mitochondrial permeability transition pore (mPTP): A systematic review. Yang Y; Wang W; Tian Y; Shi J Mitochondrion; 2022 May; 64():103-111. PubMed ID: 35346868 [TBL] [Abstract][Full Text] [Related]
24. Chronic ethanol consumption enhances sensitivity to Ca(2+)-mediated opening of the mitochondrial permeability transition pore and increases cyclophilin D in liver. King AL; Swain TM; Dickinson DA; Lesort MJ; Bailey SM Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G954-66. PubMed ID: 20651005 [TBL] [Abstract][Full Text] [Related]
25. Quantification of active mitochondrial permeability transition pores using GNX-4975 inhibitor titrations provides insights into molecular identity. Richardson AP; Halestrap AP Biochem J; 2016 May; 473(9):1129-40. PubMed ID: 26920024 [TBL] [Abstract][Full Text] [Related]
26. Involvement of the mitochondrial permeability transition pore in chronic ethanol-mediated liver injury in mice. King AL; Swain TM; Mao Z; Udoh US; Oliva CR; Betancourt AM; Griguer CE; Crowe DR; Lesort M; Bailey SM Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G265-77. PubMed ID: 24356880 [TBL] [Abstract][Full Text] [Related]
28. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Halestrap AP; Brenner C Curr Med Chem; 2003 Aug; 10(16):1507-25. PubMed ID: 12871123 [TBL] [Abstract][Full Text] [Related]
29. Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury. Morciano G; Giorgi C; Bonora M; Punzetti S; Pavasini R; Wieckowski MR; Campo G; Pinton P J Mol Cell Cardiol; 2015 Jan; 78():142-53. PubMed ID: 25172387 [TBL] [Abstract][Full Text] [Related]
31. Opening of the mitochondrial permeability transition pore links mitochondrial dysfunction to insulin resistance in skeletal muscle. Taddeo EP; Laker RC; Breen DS; Akhtar YN; Kenwood BM; Liao JA; Zhang M; Fazakerley DJ; Tomsig JL; Harris TE; Keller SR; Chow JD; Lynch KR; Chokki M; Molkentin JD; Turner N; James DE; Yan Z; Hoehn KL Mol Metab; 2014 Apr; 3(2):124-34. PubMed ID: 24634818 [TBL] [Abstract][Full Text] [Related]
32. Genetic manipulation of the cardiac mitochondrial phosphate carrier does not affect permeability transition. Gutiérrez-Aguilar M; Douglas DL; Gibson AK; Domeier TL; Molkentin JD; Baines CP J Mol Cell Cardiol; 2014 Jul; 72():316-25. PubMed ID: 24768964 [TBL] [Abstract][Full Text] [Related]
33. Impaired flickering of the permeability transition pore causes SPG7 spastic paraplegia. Sambri I; Massa F; Gullo F; Meneghini S; Cassina L; Carraro M; Dina G; Quattrini A; Patanella L; Carissimo A; Iuliano A; Santorelli F; Codazzi F; Grohovaz F; Bernardi P; Becchetti A; Casari G EBioMedicine; 2020 Nov; 61():103050. PubMed ID: 33045469 [TBL] [Abstract][Full Text] [Related]
34. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. Leung AW; Varanyuwatana P; Halestrap AP J Biol Chem; 2008 Sep; 283(39):26312-23. PubMed ID: 18667415 [TBL] [Abstract][Full Text] [Related]
35. SPG7 targets the m-AAA protease complex to process MCU for uniporter assembly, Ca Hurst S; Baggett A; Csordas G; Sheu SS J Biol Chem; 2019 Jul; 294(28):10807-10818. PubMed ID: 31097542 [TBL] [Abstract][Full Text] [Related]
36. Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease. Thomas B; Banerjee R; Starkova NN; Zhang SF; Calingasan NY; Yang L; Wille E; Lorenzo BJ; Ho DJ; Beal MF; Starkov A Antioxid Redox Signal; 2012 May; 16(9):855-68. PubMed ID: 21529244 [TBL] [Abstract][Full Text] [Related]
37. Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis. Warne J; Pryce G; Hill JM; Shi X; Lennerås F; Puentes F; Kip M; Hilditch L; Walker P; Simone MI; Chan AW; Towers GJ; Coker AR; Duchen MR; Szabadkai G; Baker D; Selwood DL J Biol Chem; 2016 Feb; 291(9):4356-73. PubMed ID: 26679998 [TBL] [Abstract][Full Text] [Related]
38. Hydrogen sulfide inhibits Ca Papu John AS; Kundu S; Pushpakumar S; Amin M; Tyagi SC; Sen U Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E269-E283. PubMed ID: 31039005 [TBL] [Abstract][Full Text] [Related]